In this sensitive, specific 1251radioimmunoassay for plasma progesterone, an identical glucuronide bridge is used in the immunogen and radioligand. This apparently provides a system in which the bridge is poorly recognized and thereby avoids the excessively high affinity of the tracer for the antiserum and the consequent poor sensitivitythat commonly is found in other homologous-bridge situations.
Many such assays have been described, particularly for the estimation of drugs (1), but among the major gonadal steroids, where the high workload renders particularly valuable the attributes of '251-based assays-especially work-simplification, shorter counting times,and decreasedcosts-there is still a heavy reliance on 3H systems. Two vital features of assay performance that are often diminished by the use of radioiodinated tracers, namely sensitivity and specificity, underlie this conservatism. To incorporate 1251 into a steroid one usually must prepare a conjugate of the steroid and an iodinatable aromatic species (generally histamine, tyramine, or tyrosine methyl ester), and this is most conveniently done by using the same bridge structure (e.g., hemisuccinate or carboxymethyloxime)
as appears in the steroid-protein conjugate that is used as the immunogen (2) . Because at least a proportion of the antibodies elicited by the immunogen recognize the bridge as well asthe steroid, such radioligands generally have a higher affinity for the antibody than does the analyte, and consequently the assay is likely to be less sensitive than the corresponding system where a 3H-labeled radioligand, identical in structure with the analyte, is used. One means by which sensitivity may be restored is to vary the structure of the bridge with the aim of reducing the affinity of the radioligand for the antibody. This approach has been shown to provide a sensitive standard curve (3), but it is entirely empirical, and for a given antiserum it might be necessary to test several different bridges in the radioligand before finding one suitable. Other workers have suggested that subtle variation of the bridge can be beneficial (4) . An alternative stratagem is a heterologous-site assay, in which the bridge in the immunogen and in the tracer is attached to different positions on the steroid. Again, such systems are unpredictable:
in some cases the tracer fails to bind to the antiserum while other combinations generate sensitive standard curves (5), but these are generally accompanied by a deterioration in the specificity of the assaybecause two areas of the steroid molecule are obscured.
Despite these difficulties, both homologous-(5, 6) and heterologous-site Received Dec. 4, 1980; accepted Jan. 14, 1981.
been described, but Cameron et al. (5, 6) note that among groups of antisera that yielded acceptable assays with a 3H-labeled ligand, only exceptional antisera were suitable for use with a '251-labeled tracer.
Clearly, a major obstacle to the wider use of iodinated tracers is related to the nature of the bridging structure used to functionalize the steroid, and we have been concerned to seek potentially generalized solutions to this problem.
Kellie and co-workers (8, 9) have reported that when antisera were raised against steroid glucuronides, where the glucuronide carboxyl group was used to link the steroid to a carrier protein for preparation of the immunogen, the corresponding free steroid showed a high degree of cross reactivity.
We reasoned that such antisera must be relatively blind to the bridge and that the attachment of an iodine-bearing species to the glucuronide might permit the development of a sensitive assay.
We have used a glucuronide prepared from ila-hydroxyprogesterone, and the results obtained form the subject of this report.
Materials and Methods

General Chemical and Radioimmunoassay
Materials 5a-Pregnane-3,20-dione was from Steraloids, Croydon, Surrey, and pregn-4-en-20a-ol-3-one was from the M.R.C. Figure 1) . A solution of 76 mg of ha-progesterone glucuronide and 19mg of N-hydroxysuccinimide in 3.6 mL of dry tetrahydrofuran was treated with a solution of 34 mg of dicyclohexylcarbodiimide in 0.6 mL of dry tetrahydrofuran. An aliquot of the ethanolic solution containing 380 ng of the tyramine conjugate was evaporated in a stream of nitrogen and the residue redissolved in 10 1zL of ethyl acetate, then treated with Na'251 (1 mCi) and Chlorainine T (10 1cL of 5 mg/mL solution in 0.25 mol/L phosphate, pH 7.5) and mixed vigorously for 30s. Cysteine hydrochloride (10 1zL of 10 mg/mL in 0.05 molfL phosphate, pH 7.5) was added to reduce unused tm1, followed by potassium iodide (200 1zL of 1 mg/mL solution in 50 mmolfL phosphate, pH 7.5). The solution was extracted with 300 ML of ethyl acetate and the extract was diluted with 200 ILL of methanol, applied to a 14 X 1 cm column of Sephadex LH 20, and eluted with ethyl acetate/methanol (3/2 by vol). One-milliliter fractions were collected and fractions 8-10 were pooled and stored at 4 #{176}C. The estimated specific activity of the tracer was 500 kCi/mol, calculated by comparison of the self-displacing ability of increasing amounts of the radioligand with a standard curve of the non-iodinated conjugate (19) . Before use, an aliquot of the solution was evaporated under nitrogen and reconstituted in assay diluent.
Radioimmunoassay Procedures
Monitoring progesterone extraction from plasma. Assay buffer (200 1zL) was added to the dried residues and the contents of the tubes were vortex-mixed for 5 mm, allowed to stand for 15 mm, and then diluted to 2 mL with buffer. The tube contents were decanted into scintillation vials, 10 mL of scintillation fluid was added, and the vials were capped, shaken vigorously for 2 mm, and their radioactivity was measured.
Assay. Ethanolic standard solutions of progesterone were dispensed into assaytubes and the solvent was removed under a stream of nitrogen. Samples were prepared as dried residues in assay tubes as described above, except that no [3H]progesterone was added before the extraction. Assay buffer (200 1zL) was added to the contents of all tubes, which were vortex-mixed for 5mm and allowed to stand at room temperature for 15 mm. Radioligand (13 fmol; about 6000 counts/mm when first prepared; 50 ILL) and antiserum at 6000-fold dilution (50 itL) were added, the tubes' contents were vortex-mixed briefly and allowed to stand at room temperature for 2 h. Sepharose-coupled donkey anti-rabbit serum, 20-fold diluted (100 ILL) was added, the tubes were agitated for 0.5 h, and separated by two cycles of the previously described sucrose layer technique (20, 21) . Then assay diluent (0.5 mL) was added rapidly and the solution allowed to settle for 5 mm. Sucrose CLINICAL CHEMISTRY, Vol. 27, No. 4, 1981 597 mL) of the tube contents was aspirated to waste. A further 0.5 mL of assay diluent was added, the cycle was repeated as above, and the remaining (antibody-bound) fraction was counted with the gamma counter. We processed the data by computer, using a modified four-parameter logistic fit (22) to construct the dose-response curve; results were corrected for extraction recovery.
Results
Antisera.
Three of the six rabbits produced antisera of acceptable titre, and Figure 2 shows the standard curves obtained with tritiated and '25iodinated radioligands from one of these antisera (R6/l0). The two remaining antisera gave insensitive standard curves with both radioligands, the '25iodinated tracer affording standard curves that were between three-and 10-fold less sensitive (as measured at 50% tracer displacement) than those obtained with the tritiated ligand. No consistent effect attributable to the different immunogen dose levels was observed.
lodinated radioligand.
The observed specific activity is about 25% of the theoretically attainable value for a homogeneous mono-'I-labeled compound. Attempts to improve the specific activity by reduction of the mass of conjugate taken for iodination were vitiated by a concomitant reduction in the percentage incorporation.
Specificity.
Major cross reactions at 50% displacement The percentage recoveries by petroleum ether extraction, as described above, of [3Hprogesterone added to low-, medium-, and high-concentration pools were (mean ± SD) 92.6 ± 1.3, 92.3 ± 1.2, and 94.9 ± 2.1, respectively. Because of the observed consistency of the results, analytical recoveries for individual samples were not measured. Instead an overall recovery correction, determined for the three pools at the beginning of each assay, was applied.
Precision
and accuracy. 
Discussion
The principal object of the study was to examine the utility of a glucuronide bridge as a weakly antigenic subunit, whose common presence in an immunogen and radioiodinated tracer would be poorly recognized by an antibody. Although none of the antibodies obtained in the various antisera were entirely indifferent to the presence of the bridge structure, the relatively small rightward shifts of standard curves (compared with those obtained with tritiated progesterone as radioligand) suggest that the use of immunogen/tracer pairs which incorporate a homologous-site glucuronide bridge is likely to facilitate the establishment of sensitive and specific iodine-125-based radioimmunoassays for haptens. The single-extraction procedure used is a minor and more reproducible revision of the method described earlier (17) and is so consistent and nearly quantitative as to obviate either the need for a double extraction or the individual monitoring of recoveries.
Use of a liquid-phase primary incubation followed by solid-phase second antibody combined a short equilibration time with the benefits to precision and convenience of a solid-phase separation system. No evidence of drift was observed; the assay is therefore well suited to handling large sample batches. Sensitivity is more than sufficient to fulfill the clinical requirement of a progesterone assay, i.e., the monitoring of luteal function. Estimation of progesterone concentrations during the follicular phase or in male plasma would necessitate extraction of larger plasma volumes.
In conclusion, the use of the glucuronide bridge has enabled as radioligands Total count rates for the mass of tracers added were 4000 and 10 000 cpm. respectively us to develop a specific progesterone radioimmunoassay in which a 'WI-labeled tracer is used, which has sensitivity much improved over that previously reported (26) with hemisuccmnate-bridged compounds ( Figure 3 ). The glucuronide appears to offer a rational means to attach external labels to haptens without incurring the need to select an exceptional antiserum from a large group, and we intend to investigate other models to establish more firmly the generality of this approach.
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